Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. With the conditional approval, ADCL can immediately employ the Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0 Assay (the “Linea 2.0 The Linea 2.0 The Linea 2.0 Dr. James A.

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

MedicalJane

DECEMBER 13, 2017

Introduced in July 2014, New York’s medical marijuana program has been a work in progress from the get-go. The state recently announced an expansion to its program that is beginning to open the door to improved patient access. These changes included adding chronic pain and PTSD to its list of qualifying medical conditions.

Programs 49

Programs Patients Chronic Pain Marijuana 49

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Cannabis Law Report

DECEMBER 7, 2021

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. 1.69, 95% CI [1.20–2.36])

Safety 52

Safety Cannabinoids Events Data 52

Puff Puff Post

SEPTEMBER 16, 2019

Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.

Programs 40

Programs Research and Development Education Treatment 40

Illinois News Joint

MAY 12, 2023

A third item states that, “The Department shall authorize a dispensing organization that has been unable to find a suitable location within the BLS Region in which it was awarded a license to transfer its Conditional Adult Use Dispensing Organization License to another BLS Region specified by the Department.” “BLS

Packaging 101

Packaging Agriculture Cannabis Cultivation 101

Illinois News Joint

FEBRUARY 7, 2023

The Disparity and Availability Study’s purpose is to collect and analyze data and will report on whether discrimination exists in the Illinois cannabis industry. Illinois’ current cannabis licensing program does not consider race and gender for licensing. To learn about cannabis-friendly events in Illinois, visit here.

Agriculture 76

Agriculture Cannabis Policy Dispensary 76

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

JULY 9, 2021

As we begin design of Phase 2 of our buildout, we will add more square feet to our facilities to continue to meet the demand of the medical program in West Virginia.”. Forward-looking statements may relate to future financial conditions, results of operations, plans, objectives, performance or business developments.

Research and Development 105

Research and Development Cultivation Seed-To-Sale Dispensary 105

Cannabis Law Report

JUNE 1, 2021

The acquisition is expected to close in Q3 2021, subject to closing conditions and covenants customary for this type of transaction, including, without limitation, obtaining MED and local licensing approval. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. About Schwazze.

Seed-To-Sale 85

Seed-To-Sale Cultivation Events Strains 85

Cannabis Law Report

JULY 28, 2021

Active research includes applications of machine learning and data mining as a member of the University of Alberta computational psychiatry group. These statements relate to future events or future performance. Cautionary Note on Forward-Looking Information. This news release contains forward?looking looking statements and forward?looking

Research and Development 105

Research and Development Events Media Data 105

Cannabis Law Report

JANUARY 6, 2022

Anderson will be responsible for Anebulo’s global investor relations and public relations programs. He serves as the primary spokesperson and point of contact with the analyst and investment community and is also responsible for the timely dissemination of information and data to these important stakeholders. Scott Anderson.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Programs 52

SpeedWeed

APRIL 29, 2021

Curaleaf also hosts panel discussions and support events for all team members: . OSCC provides cannabis products to compassion centers operating in Portsmouth, Providence and Warwick that serve more than 18,000 cannabis patients in Rhode Island’s medical program. PRIDE/QUSH (Queer-Centered Unity and Service Huddle). billion overall.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

MARCH 3, 2022

A representative of the Impact Forum told Marijuana Moment in an email that the event “is private and we do not issue transcripts, audio or video.”. “No He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs. He reportedly said definitively at the event that “CBD works.”.

Media 52

Media CBD Events THC 52

Cannabis Law Report

FEBRUARY 28, 2022

— MedMen to launch its global trademark licensing program beginning in Florida. The transaction is subject to customary closing conditions, including applicable regulatory approvals. first loyalty program, provides exclusive access to promotions, product drops and content. store pickup. MedMen Buds, an industry?first

Events 52

Events Retail Business Dispensary 52

Cannabis Law Report

NOVEMBER 3, 2021

(“Leafly”), one of the world’s leading cannabis discovery marketplaces and resources, today released its inaugural Cannabis Harvest Report—the first look at cannabis crop data, insights, and projections across the 11 states where Americans can currently purchase both adult-use and medical cannabis. With a wholesale harvest value of $6.2

Agriculture 52

Agriculture Data eCommerce Cannabis 52

Cannabis Law Report

JANUARY 20, 2022

Cumulatively, all of the 10-year agreements under Agrify’s TTK Solution program are currently projected to generate an estimated $850 million in total revenue. Agrify brings data, science, and technology to its customers for unparalleled control over cultivation and extraction. About Agrify TTK Solution.

Extraction 52

Extraction Cultivation Hemp Data 52

Cannabis Law Report

JUNE 7, 2021

NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. 1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. P1 (Brazil), and B.1.526

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

JUNE 2, 2021

“Each of the six locations has been issued a conditional RSA and work will begin immediately upon closing the Transactions to convert the stores to the Value Buds banner, and to obtain approval to open from the AGCO, just in time to take full advantage of the anticipated summer demand.” million in cash and $1.1

Business 105

Business Hybrid Retail Conditions 105

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company. PharmaDrug’s cancer program is based on cepharanthine’s known anti-cancer activities.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Dykema (Cannabis Law Blog)

MARCH 25, 2020

The Department of Agriculture granted approval to the first cultivation center to begin actually growing cannabis on July 10, 2015, and the facility planted its first seeds three days later, nearly two years into the four-year pilot program. According to state-released data, those patients purchased approximately $1.7

Chronic Pain 40

Chronic Pain Conditions Patients CBD 40

Veriheal

OCTOBER 5, 2020

The bill set out the qualifying conditions as well as regulations relating to possession, cultivation, and dispensaries. The Medical Marijuana Dispensary Program of Hawaii was created in order to get medical cannabis consumers to register for consuming the plant. Summary of Hawaiian Cannabis Regulations.

Edibles 52

Edibles Legalization Decriminalization Consumption 52

The Cannigma

MARCH 29, 2021

The interactions of the endocannabinoid system with the autonomic nervous system seem to be the driving force behind the reported cardiovascular adverse events [from cannabis],” wrote a group of researchers who recently reviewed years of cannabis studies 1. Cardiac-related mortality data from the U.S. increase among women 11.

Blood Pressure 143

Blood Pressure Indica THC Strains 143

Cannabis Law Report

SEPTEMBER 27, 2021

“New York continues to represent a tremendous market opportunity, and with the signing into law authorizing the establishment of an adult-use cannabis program and the expansion of the existing medical-use cannabis program, we believe this is an opportune time for Goodness Growth to execute on this highly strategic expansion.

Programs 52

Programs Patients Cultivation Dispensary 52

Project CBD

MAY 3, 2023

CannMed: For what conditions do you think CBG has the most promise? It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. Psoriasis is a well-known condition where people get not only joint pain but they also get these thick red patches and scales on their skin.

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

SpeedWeed

FEBRUARY 24, 2021

They should go to mandatory rehabilitation,” he made clear at a campaign event in Kenosha, Wisconsin this September. If court-appointed rehab is mandatory, what happens if you don’t show up or don’t complete the program to the government’s satisfaction? Judges and drug court advocates skew the data. What’s wrong with rehab?

Treatment 52

Treatment Data Programs Decriminalization 52

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S. Net revenue.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

FEBRUARY 2, 2022

The Amendments require that the Company make a mandatory prepayment in the event of the sale of certain assets. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. The Company will prepay US$20.0 million on the Term Loans and pay a fee of US$1.0

Events 52

Events Business Retail Conditions 52

Cannabis Law Report

JULY 2, 2021

Under the terms of the agreement, Columbia Care purchased an exclusive option to acquire all outstanding membership interests of the dispensary operations on the first anniversary of the date upon which all four of the dispensaries have been issued certificates of operation under Ohio’s Medical Marijuana Control Program.

Dispensary 66

Dispensary Seed-To-Sale Research and Development Cultivation 66

Cannabis Law Report

AUGUST 18, 2021

cannabis legalization (or Tilray’s waiver of such condition).In cannabis legalization (or Tilray’s waiver of such condition).In MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. Learn more about MedMen at www.medmen.com.

Events 105

Events Retail Research and Development Conditions 105

Puff Puff Post

NOVEMBER 5, 2019

. “This filing follows the successful conclusion of an extensive preclinical development program that included 20 safety pharmacology and toxicology studies with treatment up to 28 days,” says Alexandra Mancini, Senior Vice President of Clinical and Regulatory Affairs.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. dollars in thousands (except for share and per share data). . . Fortified Balance Sheet.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

CannaMD

DECEMBER 9, 2020

The authors also list a range of additional conditions for which there are possible benefits of cannabis therapies, including opiate withdraw, dystonia, glaucoma, Alzheimer’s disease, anxiety and depression, anti-tumor effects, inflammatory bowel diseases, Parkinson’s disease, and sleep disorders. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111